CHRONIC GVHD

Clinical trials for CHRONIC GVHD explained in plain language.

Never miss a new study

Get alerted when new CHRONIC GVHD trials appear

Sign up with your email to follow new studies for CHRONIC GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 4 Completed 1 Terminated 1

Promising drug for Post-Transplant blood issues stalls after single patient

Disease control Terminated

This study tested a drug called fostamatinib for people who develop low blood cell counts after a stem cell transplant. The goal was to see if the drug could help stabilize red blood cells or platelets without needing transfusions. The study was stopped early after enrolling only…

Matched conditions: CHRONIC GVHD

Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated May 17, 2026 07:53 UTC

CHRONIC GVHD

Get alerted when new CHRONIC GVHD trials appear

Promising drug for Post-Transplant blood issues stalls after single patient